You are here

  • Home
  • Archive
  • Volume 82, Issue 12
  • Correspondence on “Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry” by Machado et al

Citation Tools

Article menu
Correspondence
Correspondence on “Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry” by Machado et al
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bourguiba R, Delplanque M, Savey L French national reference Center for autoinflammatory diseases and AA amyloidosis (CEREMAIA), et al
Correspondence on “Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry” by Machado et al
Annals of the Rheumatic Diseases 2023;82:e228.